deltatrials
Terminated PHASE3 NCT00394212

Incisionless Treatment for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass

Randomized Evaluation of Endoscopic Suturing Transorally for Anastomotic Outlet Reduction (RESTORe) for Patients With Inadequate Weight Loss Following Roux-en-Y Gastric Bypass Surgery

Sponsor: C. R. Bard

Conditions Obesity
Interventions Sham Endoscopy Transoral Suturing
Updated 8 times since 2017 Last updated: Aug 12, 2016 Started: Nov 30, 2006 Primary completion: Sep 30, 2008 Completion: May 31, 2009

This PHASE3 trial investigates Obesity and is currently terminated or withdrawn. C. R. Bard leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • C. R. Bard
Data source: C. R. Bard

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Baltimore, United States
  • • Boston, United States
  • • Cleveland, United States
  • • Dallas, United States
  • • Denver, United States
  • • Lebanon, United States
  • • Milwaukee, United States
  • • New York, United States
  • • Philadelphia, United States
  • • St Louis, United States